Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a randomized controlled study to evaluate the efficacy and safety of toripalimab plus capecitabine as postoperative adjuvant therapy for patients with resectable advanced extrahepatic biliary tract cancer.
Epistemonikos ID: af0f8a82a7d7660f807f28ccc3614f2fe310aa8a
First added on: Jan 01, 2025